In light of the SCCS opinion, it can be concluded that there is a potential risk to human health arising from the use of Hydroxyapatite (nano) in cosmetic products when the concentration of that substance exceeds certain levels or when it is used in sprayable products that might lead to exposure of the consumer’s lungs to nanoparticles by inhalation. Therefore, the use of Hydroxyapatite (nano) in cosmetic products should be restricted to a maximum concentration of 10 % in toothpaste and of 0,465 % in mouthwash with the respective characteristics, while the use of Hydroxyapatite (nano) in applications that may lead to exposure of the end user’s lungs by inhalation should not be allowed.
Recital 7, Regulation (EU) 2024/858
In forcesince 14 Mar 2024